XML 51 R23.htm IDEA: XBRL DOCUMENT v3.22.0.1
EQUITY
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Equity EQUITY
 Common StockCapital in Excess
of Par Value
of Stock		Accumulated Other Comprehensive LossRetained
Earnings		Treasury StockNoncontrolling
Interest
Dollars and Shares in MillionsSharesPar ValueSharesCost
Balance at January 1, 20192,208 $221 $2,081 $(2,762)$34,065 576 $(19,574)$96 
Accounting change - cumulative effect(a)
— — — — 5 — — — 
Adjusted balance at January 1, 20192,208 221 2,081 (2,762)34,070 576 (19,574)96 
Net earnings— — — — 3,439 — — 21 
Other Comprehensive Income/(Loss)— — — 1,242 — — — — 
Celgene acquisition715 71 42,721 — — — — — 
Cash dividends declared(b)
— — — — (3,035)— — — 
Share repurchase program— — (1,400)— — 105 (5,900)— 
Stock compensation— — 307 — — (9)117 — 
Distributions— — — — — — — (17)
Balance at December 31, 20192,923 292 43,709 (1,520)34,474 672 (25,357)100 
Net loss— — — — (9,015)— — 20 
Other Comprehensive Income/(Loss)— — — (319)— — — — 
Cash dividends declared(b)
— — — — (4,178)— — — 
Share repurchase program— — 1,400 — — 43 (2,993)— 
Stock compensation— — (784)— — (36)2,113 — 
Distributions— — — — — — — (60)
Balance at December 31, 20202,923 292 44,325 (1,839)21,281 679 (26,237)60 
Net earnings— — — — 6,994 — — 20 
Other Comprehensive Income/(Loss)— — — 571 — — — — 
Cash dividends declared(b)
— — — — (4,455)— — — 
Share repurchase program— — — — — 102 (6,240)— 
Stock compensation— — 36 — — (34)1,218 — 
Distributions— — — — — — — (20)
Balance at December 31, 20212,923 $292 $44,361 $(1,268)$23,820 747 $(31,259)$60 
(a)    Cumulative effect resulting from adoption of ASU 2014-09 and ASU 2016-02.
(b)    Cash dividends declared per common share were $2.01 in 2021, $1.84 in 2020 and $1.68 in 2019.

BMS has a share repurchase program, authorized by its Board of Directors, allowing for repurchases of its shares effected in the open market or through privately negotiated transactions in compliance with Rule 10b-18 under the Exchange Act, including through Rule 10b5-1 trading plans. The share repurchase program does not have an expiration date and may be suspended or discontinued at any time. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized utilizing the first-in first-out method. The outstanding share repurchase authority authorization under the program was $4.4 billion as of December 31, 2020.

In January and December 2021, the Board of Directors approved an increase of $2.0 billion and $15.0 billion, respectively, to the share repurchase authorization for BMS’s common stock. BMS repurchased approximately 102 million shares of its common stock for $6.2 billion in 2021. The remaining share repurchase capacity under the share repurchase program was approximately $15.2 billion as of December 31, 2021.

In 2020, BMS repurchased approximately 27 million shares of its common stock for $1.6 billion. In 2020, the 2019 ASR was settled and approximately 16 million shares of common stock were received by BMS and transferred to treasury stock.
In 2019, BMS executed ASR agreements to repurchase an aggregate $7.0 billion of common stock. These ASR agreements were funded with cash on-hand. Approximately 99 million shares of common stock (80% of the $7.0 billion aggregate repurchase price) were received by BMS and included in treasury stock. In addition, approximately 6 million shares of common stock were repurchased for $300 million.

In February 2022, BMS executed ASR agreements to repurchase an aggregate $5.0 billion of its common stock. These ASR agreements were funded with cash on-hand and are expected to settle during the second and third quarters of 2022. The total number of shares to be repurchased under the ASR agreements will be based on volume-weighted average prices of BMS's common stock during the terms of the ASR transactions less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreements.

The components of Other Comprehensive Income/(Loss) were as follows:
 Year Ended December 31,
202120202019
Dollars in MillionsPretaxTaxAfter TaxPretaxTaxAfter TaxPretaxTaxAfter Tax
Derivatives qualifying as cash flow hedges:
Unrealized gains/(losses)$364 $(34)$330 $(216)$7 $(209)$65 $(7)$58 
Reclassified to net earnings(a)
95 (10)85 (54)7 (47)(103)13 (90)
Derivatives qualifying as cash flow hedges459 (44)415 (270)14 (256)(38)6 (32)
Pension and postretirement benefits:
Actuarial gains/(losses)220 (40)180 (134)25 (109)(143)28 (115)
Amortization(b)
41 (10)31 33 (6)27 55 (11)44 
Settlements(b)
(6)1 (5)10 (3)7 1,640 (366)1,274 
Pension and postretirement benefits255 (49)206 (91)16 (75)1,552 (349)1,203 
Marketable debt securities:
Unrealized (losses)gains(11)2 (9)7 (1)6 42 (9)33 
Realized (gains)/losses(b)
— — — (1)— (1)3 — 3 
Marketable debt securities(11)2 (9)6 (1)5 45 (9)36 
Foreign currency translation(14)(27)(41)(19)26 7 43 (8)35 
Other Comprehensive Income/(Loss)$689 $(118)$571 $(374)$55 $(319)$1,602 $(360)$1,242 
(a)    Included in Cost of products sold.
(b)    Included in Other (income)/expense, net.

The accumulated balances related to each component of Other Comprehensive Income/(Loss), net of taxes, were as follows:
 December 31,
Dollars in Millions20212020
Derivatives qualifying as cash flow hedges$178 $(237)
Pension and postretirement benefits(768)(974)
Marketable debt securities2 11 
Foreign currency translation(680)(639)
Accumulated other comprehensive loss$(1,268)$(1,839)